Previous researches have shown the up-regulation of BTLA in gastric cancer (51), pancreatic cancer (52) and lymphocytic leukemia (53) and BTLA overexpression has been found to be associated with an immunosuppressive microenvironment (54). This evidence concerns the gene BTLA and pancreatic neoplasm.